PVM Distinguished Professor Suresh Mittal to Speak at Purdue’s Westwood Lecture Series

The Westwood Lecture Series is part of Purdue President Mung Chiang’s efforts aimed at enhancing the intellectual vibrancy of the Purdue West Lafayette campus, and the next featured speaker is Purdue Veterinary Medicine’s Distinguished Professor of Virology, Dr. Suresh Mittal. His presentation entitled, “Universal Influenza Vaccine — An Aspiration or Reality?” is scheduled for January 28. Registration is now open for the lecture, which will take place at Westwood from 4:30 – 5:30 p.m. Space will be limited to the first 50 faculty who register online.

The Westwood Lecture Series is an opportunity for Purdue faculty and staff members engaged in the research topic to interact with colleagues on scholarly work. Dr. Mittal explains that current seasonal influenza vaccines offer strain-specific protection, and thus, are less effective against mismatched strains. Besides, several zoonotic avian influenza viruses — e.g., H5N1, H7N7, H7N9 or H9N2 — pose a significant pandemic risk since seasonal influenza vaccines fail to protect against the distinct avian influenza viruses. Moreover, ongoing cases of avian A/H5N1 influenza virus (clade 2.3.4.4b) in cattle and its transmission to cattle, poultry and cats further highlight the potential danger of avian influenza viruses. Therefore, developing a universal influenza vaccine that confers better protection than the currently available seasonal or pandemic influenza vaccines will be vital for influenza preparedness. Dr. Mittal adds, “Our work at Purdue University, using a unique adenoviral vector platform with innovative antigen design, demonstrates the feasibility of designing an effective universal influenza vaccine.”

In addition to his role as a member of the Department of Comparative Pathobiology faculty, Dr. Mittal serves as the infectious disease group leader for the Purdue Institute of Inflammation, Immunology and Infectious Disease. With more than 30 years of experience working with adenoviral vectors, Dr. Mittal is regarded as a leader in designing human and nonhuman adenoviral vectors for recombinant vaccines. Over the last 20 years, he has acquired expertise in adenoviral vector-based vaccines for seasonal and potential pandemic influenza viruses, and his ongoing work has contributed to the development of vaccines for influenza, COVID-19 and tuberculosis. Dr. Mittal has extensive expertise in designing novel intervention strategies for emerging and remerging infectious agents, and his research continues to be supported with funding from the National Institutes of Health.

Writer(s): PVM News | pvmnews@purdue.edu

Recent Stories

Purdue Veterinary Medicine Fosters Learning and Engagement linking people, animals and agriculture at Indiana State Fair

In just more than two weeks’ time during the month of August, the 2026 Indiana State Fair served up an abundance of fun, food, and festivities, and in the midst of it all, faculty, staff and students from the Purdue University College of Veterinary Medicine were visible and vibrant participants. Purdue Veterinary Medicine representatives made a difference in a variety of ways, from providing veterinary care for the animals on the fairgrounds, to helping animal agriculture organizations as volunteers, to conducting veterinary checks on animals at the annual 4-H State Fair Dog Show and Cat Show.

“Paws Up” for Jennifer Danaher – brought to you by the PVM Wellness Committee

This week we express our gratitude to Jennifer Danaher, who is department secretary for Veterinary Clinical Sciences.

‘Purdue Pursuits’: A PVM angle on Purdue’s teaching and learning reading groups

Crafting meaningful and engaging course experiences has been at the top of Dielson Vieira’s mind ever since he joined the Purdue University College of Veterinary Medicine’s faculty in 2024. As a clinical assistant professor in the Department of Basic Medical Sciences, Vieira is already adept at applying innovative teaching practices to classroom environments, but that doesn’t stop him from seeking out new ideas, approaches and perspectives — insights he gains through outlets like Purdue’s teaching and learning reading groups.

Top tier biology journal publishes PVM study that unlocks secrets of a drug-resistant fungal pathogen, which causes serious infections in humans

Though the name “Candida auris” is far from a household term, public health experts know it well because the multi-drug-resistant fungal pathogen, which causes serious human infections, has been classified as an urgent threat by the U.S. Centers for Disease Control and Prevention (CDC) Antibiotic Threats Report (2019). Dr. Shankar Thangamani, Associate Professor of Microbiology and University Faculty Scholar in the Purdue University College of Veterinary Medicine’s Department of Comparative Pathobiology, is researching C. auris, aided by a 2.4 million grant from the National Institutes of Health (NIH). New research findings, just published in Nature Microbiology, show how C. auris adapts and evades the immune system.

In Print: ‘Translational Research Methods for Tauopathies’

A just-published 300-page volume edited by Jessica Fortin, Purdue assistant professor in the College of Veterinary Medicine’s Department of Basic Medical Sciences, provides a significant new resource for researchers studying a group of neurodegenerative diseases known as tauopathies. “Translational Research Methods for Tauopathies” provides detailed protocols intentionally selected to serve as a basis for research laboratories seeking to further treatments for such debilitating neurodegenerative diseases as Alzheimer’s and chronic traumatic encephalopathy (CTE).